Stevanato Group S.p.A. (NYSE:STVN – Get Free Report) CFO Lago Marco Dal sold 4,209 shares of the firm’s stock in a transaction that occurred on Friday, August 7th. The shares were sold at an average price of €20.09, for a total transaction of €84,558.81. Following the completion of the transaction, the chief financial officer directly owned 81,144 shares of the company’s stock, valued at approximately €1,630,182.96. The trade was a 4.93% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
Stevanato Group Trading Up 0.1%
Shares of STVN stock opened at €21.27 on Thursday. Stevanato Group S.p.A. has a fifty-two week low of €12.89 and a fifty-two week high of €28.00. The company has a 50 day moving average price of €18.93 and a 200 day moving average price of €17.01. The stock has a market capitalization of $6.44 billion, a P/E ratio of 37.98, a price-to-earnings-growth ratio of 1.76 and a beta of 0.77. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.08 and a current ratio of 1.61.
Institutional Trading of Stevanato Group
Large investors have recently made changes to their positions in the company. Handelsbanken Fonder AB lifted its stake in Stevanato Group by 26.4% in the second quarter. Handelsbanken Fonder AB now owns 30,600 shares of the company’s stock worth $553,000 after acquiring an additional 6,400 shares during the last quarter. First Bank & Trust grew its holdings in Stevanato Group by 3.4% during the 2nd quarter. First Bank & Trust now owns 18,417 shares of the company’s stock worth $333,000 after acquiring an additional 603 shares in the last quarter. Cooper Investors PTY Ltd. increased its position in shares of Stevanato Group by 4.4% in the 2nd quarter. Cooper Investors PTY Ltd. now owns 668,494 shares of the company’s stock valued at $12,080,000 after purchasing an additional 28,265 shares during the last quarter. Confluence Investment Management LLC purchased a new stake in shares of Stevanato Group in the 2nd quarter valued at approximately $6,062,000. Finally, Glenmede Trust Co. NA raised its holdings in shares of Stevanato Group by 29.5% in the 1st quarter. Glenmede Trust Co. NA now owns 38,461 shares of the company’s stock valued at $529,000 after purchasing an additional 8,770 shares in the last quarter.
Analyst Upgrades and Downgrades
Read Our Latest Analysis on STVN
Stevanato Group Company Profile
Stevanato Group is a global provider of primary packaging solutions and related services for the pharmaceutical and biotech industries. The company specializes in the design, development and manufacturing of glass drug containers such as vials, cartridges and pre-fillable syringes, as well as advanced inspection systems and assembly equipment. Its integrated offerings cover the entire packaging supply chain, from component production to bespoke filling lines and serialization technology.
In addition to its core glass business, Stevanato Group delivers engineering services and process validation support to pharmaceutical customers.
Read More
- Five stocks we like better than Stevanato Group
- GE Vernova’s AI Power Boom Faces a Profit Test
- Cardinal Health Earnings: Can Perfection Get Priced In Twice?
- Nebius’ Q2 Beat Shows the AI Bottleneck Is Capacity, Not Demand
- Legacy Jet Builders Stall While Embraer Accelerates to New Highs
Receive News & Ratings for Stevanato Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stevanato Group and related companies with MarketBeat.com's FREE daily email newsletter.
